Sarissa Capital Management LP
An institutional investment manager in GREENWICH, CT. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1577524.
- Reported value$177.9m
- Positions10
Holdings: 10 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Innoviva IncINVA | COM | 45781M101 | 42.9 | 24.1% | 1,890,604 | Reduced−240,346 | |
| Ironwood Pharmaceuticals IncIRWD | COM CL A | 46333X108 | 38.7 | 21.7% | 9,188,635 | Unchanged | |
| Amarin Corp plcAMRN | SPONSORED ADR | 023111404 | 26.7 | 15.0% | 1,673,395 | Unchanged | |
| Neurocrine Biosciences IncNBIX | COM | 64125C109 | 19.6 | 11.0% | 116,533 | Unchanged | |
| Cytokinetics IncCYTK | COM NEW | 23282W605 | 19.5 | 10.9% | 228,623 | Unchanged | |
| Lantheus Holdings IncLNTH | COM | 516544103 | 18.5 | 10.4% | 166,919 | Unchanged | |
| Biohaven Ltd | COM | G1110E107 | 8.7 | 4.9% | 582,312 | Added+19,128 | |
| Regeneron PharmaceuticalsREGN | COM | 75886F107 | 2.6 | 1.5% | 4,190 | Unchanged | |
| VOR Biopharma IncVOR | COM NEW | 929033207 | 0.5 | 0.3% | 25,399 | Unchanged | |
| Biogen IncBIIB | COM | 09062X103 | 0.2 | 0.1% | 950 | New+950 |
Source: SEC EDGAR, Form 13F-HR, accession 0000899140-26-000879 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.